Aiaal Lazarev

Recent publications · Crossref

5 total works indexed

1. Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

   · 2019 · cited 2,788x

2. The ATLAS Experiment at the CERN Large Hadron Collider

   · 2008 · cited 1,575x

3. Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

   · 2019 · cited 1,477x

4. Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial

   · 2018 · cited 1,076x

5. The ATLAS Simulation Infrastructure

   · 2010 · cited 1,037x

via Crossref · CC0

Wikidata facts